ETF PRO AINovember 17, 2026
XPH SPDR S&P Pharmaceuticals ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.35%expense ratio
$528Mfund assets
+16.7%return, YTD
—return, 1 year
+$50Mnet flow, 1 month
+$263Mnet flow, 1 year
24.5%realized volatility, 1y
-16.5%worst drawdown, 1y
Top ten holdings
| 1 | XERS XERIS BIOPHARMA HOLDINGS | 4.27% |
| 2 | MANE VERADERMICS INC | 2.69% |
| 3 | LLY ELI LILLY | 2.51% |
| 4 | PCRX PACIRA BIOSCIENCES | 2.52% |
| 5 | VTRS VIATRIS | 2.48% |
| 6 | AMRX AMNEAL PHARMACEUTICALS | 2.49% |
| 7 | MAZE Maze Therapeutics | 2.58% |
| 8 | ZTS ZOETIS | 2.24% |
| 9 | RPRX ROYALTY PHARMA | 2.25% |
| 10 | PRGO PERRIGO CO | 2.23% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS